Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1984 Dec 15;131(12):1457–1460.

Increased prevalence of mitral valve prolapse in patients with migraine.

J D Spence, D G Wong, L J Melendez, P M Nichol, J D Brown
PMCID: PMC1440340  PMID: 6498701

Abstract

Patients with classic migraine (69 women and 31 men) selected randomly from a practice list of over 1000 were matched for age, sex and neighbourhood with 100 people who did not have headache problems, and both groups underwent M-mode and two-dimensional echocardiography and clinical examination by cardiologists blinded to the subjects' clinical status. The mean ages were 34.9 +/- 11.3 years for the migraine group and 33.1 +/- 9.9 years for the control group. Definite and possible mitral valve prolapse (MVP), diagnosed according to predefined echocardiographic criteria, were found about twice as often in the migraine group as in the control group (in 15 v. 7 and 16 v. 8 patients respectively); the echocardiograms were definitely normal in 69 migraine patients and 85 controls (chi 2 = 8.39, p less than 0.025). Altogether 25% of the migraine group and 11% of the control group had evidence of MVP from a combination of the echocardiographic and auscultatory findings (chi 2 = 5.72, p less than 0.025). The odds ratio was 2.7, with 95% confidence limits of 1.17 and 6.29. The association between migraine and MVP has implications for the understanding of platelet abnormalities and episodes of cerebral ischemia occurring in both these conditions.

Full text

PDF
1457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amat G., Louis P. J., Loisy C., Centonze V., Pelage S. Migraine and the mitral valve prolapse syndrome. Adv Neurol. 1982;33:27–29. [PubMed] [Google Scholar]
  2. Anthony M., Hinterberger H., Lance J. W. Plasma serotonin in migraine and stress. Arch Neurol. 1967 May;16(5):544–552. doi: 10.1001/archneur.1967.00470230096013. [DOI] [PubMed] [Google Scholar]
  3. Barnett H. J., Boughner D. R., Taylor D. W., Cooper P. E., Kostuk W. J., Nichol P. M. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med. 1980 Jan 17;302(3):139–144. doi: 10.1056/NEJM198001173020303. [DOI] [PubMed] [Google Scholar]
  4. Barnett H. J. Embolism in mitral valve prolapse. Annu Rev Med. 1982;33:489–507. doi: 10.1146/annurev.me.33.020182.002421. [DOI] [PubMed] [Google Scholar]
  5. CONNOR R. C. Complicated migraine. A study of permanent neurological and visual defects caused by migraine. Lancet. 1962 Nov 24;2(7265):1072–1075. doi: 10.1016/s0140-6736(62)90782-1. [DOI] [PubMed] [Google Scholar]
  6. Caplan L. R., Weiner H., Weintraub R. M., Austen W. G. "Migrainous" neurologic dysfunction in patients with prosthetic cardiac valves. Headache. 1976 Nov;16(5):218–221. doi: 10.1111/j.1526-4610.1976.hed1605218.x. [DOI] [PubMed] [Google Scholar]
  7. Couch J. R., Hassanein R. S. Platelet aggregability in migraine. Neurology. 1977 Sep;27(9):843–848. doi: 10.1212/wnl.27.9.843. [DOI] [PubMed] [Google Scholar]
  8. Curran D. A., Hinterberger H., Lance J. W. Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain. 1965 Dec;88(5):997–1010. doi: 10.1093/brain/88.5.997. [DOI] [PubMed] [Google Scholar]
  9. Dalsgaard-Nielsen J., le Fèvre Honoré P., Zeeberg I. Changes in platelet function and blood serotonin level in migraine patients during treatment with femoxetine. Acta Neurol Scand. 1982 Aug;66(2):191–198. doi: 10.1111/j.1600-0404.1982.tb04516.x. [DOI] [PubMed] [Google Scholar]
  10. Dalsgaard-Nielsen T., Genefke I. K. Serotonin (5-hydroxytryptamine) release and uptake in platelets from healthy persons and migrainous patients in attack-free intervals. Headache. 1974 Apr;14(1):26–32. doi: 10.1111/j.1526-4610.1974.hed1401026.x. [DOI] [PubMed] [Google Scholar]
  11. Deshmukh S. V., Meyer J. S. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache. 1977 Jul;17(3):101–108. doi: 10.1111/j.1526-4610.1977.hed1703101.x. [DOI] [PubMed] [Google Scholar]
  12. Deshmukh S. V., Meyer J. S., Mouche R. J. Platelet dysfunction in migraine: effect of self-medication with aspirin. Thromb Haemost. 1976 Nov 30;36(2):319–324. [PubMed] [Google Scholar]
  13. Fisher M., Weiner B., Ockene I. S., Forsberg A., Duffy C. P., Levine P. H. Platelet activation and mitral valve prolapse. Neurology. 1983 Mar;33(3):384–386. doi: 10.1212/wnl.33.3.384. [DOI] [PubMed] [Google Scholar]
  14. GUEST I. A., WOOLF A. L. FATAL INFARCTION OF THE BRAIN IN MIGRAINE. Br Med J. 1964 Jan 25;1(5377):225–226. [PMC free article] [PubMed] [Google Scholar]
  15. Gawel M., Burkitt M., Rose F. C. The platelet release reaction during migraine attacks. Headache. 1979 Sep;19(6):323–327. doi: 10.1111/j.1526-4610.1979.hed1906323.x. [DOI] [PubMed] [Google Scholar]
  16. HARDISTY R. M., STACEY R. S. 5-Hydroxytryptamine in normal human platelets. J Physiol. 1955 Dec 29;130(3):711–720. doi: 10.1113/jphysiol.1955.sp005437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hancock E. W., Cohn K. The syndrome associated with midsystolic click and late systolic murmur. Am J Med. 1966 Aug;41(2):183–196. doi: 10.1016/0002-9343(66)90015-5. [DOI] [PubMed] [Google Scholar]
  18. Hanington E. Migraine. A platelet hypothesis. Biomedicine. 1979 Jun;30(2):65–66. [PubMed] [Google Scholar]
  19. Hanson M. R., Conomy J. P., Hodgman J. R. Brain events associated with mitral valve prolapse. Stroke. 1980 Sep-Oct;11(5):499–506. doi: 10.1161/01.str.11.5.499. [DOI] [PubMed] [Google Scholar]
  20. Jones H. R., Jr, Naggar C. Z., Seljan M. P., Downing L. L. Mitral valve prolapse and cerebral ischemic events. A comparison between a neurology population with stroke and a cardiology population with mitral valve prolapse observed for five years. Stroke. 1982 Jul-Aug;13(4):451–453. doi: 10.1161/01.str.13.4.451. [DOI] [PubMed] [Google Scholar]
  21. Kostuk W. J., Boughner D. R., Barnett H. J., Silver M. D. Strokes: A complication of mitral-leaflet prolapse? Lancet. 1977 Aug 13;2(8033):313–316. doi: 10.1016/s0140-6736(77)91482-9. [DOI] [PubMed] [Google Scholar]
  22. Litman G. I., Friedman H. M. Migraine and the mitral valve prolapse syndrome. Am Heart J. 1978 Nov;96(5):610–614. doi: 10.1016/0002-8703(78)90197-7. [DOI] [PubMed] [Google Scholar]
  23. O'Neill B. P., Mann J. D. Aspirin prophylaxis in migraine. Lancet. 1978 Dec 2;2(8101):1179–1181. doi: 10.1016/s0140-6736(78)92159-1. [DOI] [PubMed] [Google Scholar]
  24. Rice G. P., Boughner D. R., Stiller C., Ebers G. C. Familial stroke syndrome associated with mitral valve prolapse. Ann Neurol. 1980 Feb;7(2):130–134. doi: 10.1002/ana.410070207. [DOI] [PubMed] [Google Scholar]
  25. Scharf R. E., Hennerici M., Bluschke V., Lueck J., Kladetzky R. G. Cerebral ischemia in young patients: it is associated with mitral valve prolapse and abnormal platelet activity in vivo? Stroke. 1982 Jul-Aug;13(4):454–458. doi: 10.1161/01.str.13.4.454. [DOI] [PubMed] [Google Scholar]
  26. Steele P., Weily H., Rainwater J., Vogel R. Platelet survival time and thromboembolism in patients with mitral valve prolapse. Circulation. 1979 Jul;60(1):43–45. doi: 10.1161/01.cir.60.1.43. [DOI] [PubMed] [Google Scholar]
  27. Walsh P. N., Kansu T. A., Corbett J. J., Savion P. J., Goldburgh W. P., Schatz N. J. Platelets, thromboembolism and mitral valve prolapse. Circulation. 1981 Mar;63(3):552–559. doi: 10.1161/01.cir.63.3.552. [DOI] [PubMed] [Google Scholar]
  28. Watson R. T. TIA, stroke, and mitral valve prolapse. Neurology. 1979 Jun;29(6):886–889. doi: 10.1212/wnl.29.6.886. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES